Some studies showed that the short-term administration of NAD+ could ameliorate insulin secretion and response in mice with diet- and age-induced diabetes or obesity [47, 57], whereas the chronic administration of NMN could improve age-related tissue dysfunction [49] but could not address the weakness in dystrophic muscles [58]. This evidence concerns the gene INS and Obesity.